Alkeon Capital Management - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 278 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.2%.

Quarter-by-quarter ownership
Alkeon Capital Management ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$47,404,064
-20.5%
943,9280.0%0.08%
-18.3%
Q2 2023$59,656,249
+276.5%
943,928
+168.0%
0.10%
+197.1%
Q1 2023$15,844,713
-15.2%
352,183
-17.4%
0.04%
-51.4%
Q4 2022$18,674,801
-74.7%
426,268
-61.9%
0.07%
-69.7%
Q3 2022$73,758,000
+35.9%
1,119,412
+4.1%
0.24%
+63.0%
Q2 2022$54,293,000
-25.7%
1,074,900
-6.0%
0.15%0.0%
Q1 2022$73,072,000
-46.4%
1,143,899
-10.1%
0.15%
-42.1%
Q4 2021$136,298,000
+4.2%
1,272,5000.0%0.25%
+14.0%
Q3 2021$130,826,000
+38.7%
1,272,500
+18.6%
0.22%
+59.0%
Q2 2021$94,338,000
-0.2%
1,072,500
+10.3%
0.14%
-1.4%
Q1 2021$94,557,000
-6.1%
972,500
+8.4%
0.14%
-14.0%
Q4 2020$100,655,000
+21.0%
897,5000.0%0.16%
+6.5%
Q3 2020$83,198,000
+49.7%
897,500
+26.0%
0.15%
+9.2%
Q2 2020$55,575,000
-14.6%
712,500
-36.0%
0.14%
-49.3%
Q1 2020$65,059,000
+140.6%
1,112,500
+229.6%
0.28%
+175.2%
Q4 2019$27,037,000
+96.3%
337,500
+80.0%
0.10%
+106.1%
Q3 2019$13,776,000
+16.8%
187,500
+50.0%
0.05%
+4.3%
Q2 2019$11,791,000
+17.8%
125,0000.0%0.05%
-6.0%
Q1 2019$10,006,000
-17.3%
125,000
-44.3%
0.05%
-36.7%
Q4 2018$12,095,000
-22.3%
224,346
-8.5%
0.08%
+8.2%
Q2 2018$15,557,000
+52.1%
245,075
+119.7%
0.07%
+37.7%
Q1 2018$10,231,000
+1256.9%
111,575
+1015.8%
0.05%
+1225.0%
Q4 2017$754,00010,0000.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q2 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 379,090$19,037,90017.25%
DAFNA Capital Management LLC 249,521$12,530,9453.90%
Rock Springs Capital Management LP 2,685,294$134,855,4653.61%
Casdin Capital, LLC 371,378$18,650,6032.06%
Novo Holdings A/S 525,000$26,365,5001.95%
CHI Advisors LLC 92,888$4,664,8351.85%
SECTORAL ASSET MANAGEMENT INC 165,890$8,330,9961.62%
Avidity Partners Management LP 751,600$37,745,3521.52%
EMERALD ADVISERS, LLC 607,037$30,485,3931.48%
EMERALD MUTUAL FUND ADVISERS TRUST 464,321$23,318,2011.41%
View complete list of BLUEPRINT MEDICINES CORP shareholders